Category Patents/Designs/Trade Secrets

Medicines Excitement In The Netherlands – New Health Minister Announces Firm Action On “Absurd” Medicines Pricing And Gets The European Medicines Agency

The new Minister of Health of the Netherlands, Bruno Bruins, came in guns blazing when he put the pharmaceutical industry on notice and announced on 22 November to “change the rules of the game” to tackle, what he called “absurd” medicines pricing, writes Ellen 't Hoen.

‘The WHO Does Not Have A Board’: New WHO Director Pushes To Make Agency More Efficient

World Health Organization Director General Tedros Adhanom Ghebreyesus (Tedros) admonished member states at the close of this week’s special session of the WHO Executive Board charged with examining the agency’s draft work programme for 2019-2023. A trust deficit among member states leads to the multiplication of national statements, impeding efficiency, he said. Meanwhile, a number of countries called for affordable and accessible medicines, and help to manufacture generic medicines locally, while the United States pushed the role of the private sector.

Breeders Group CIOPORA Calls For New Plant Varieties To Be Patentable

A new “position paper” by a plant breeders industry group revives the argument that plant-related inventions should be patentable. New plant breeding techniques modifying the plant genome are not essentially biological processes, thus should be patentable, the paper says. The group also calls for a worldwide harmonised research exemption on plant variety rights and patents for the purpose of improving the invention.

WHO Members Delve Into Draft 5-Year Work Programme, Question Finance, Focus

World Health Organization member states’ first reactions to the secretariat-proposed draft work programme for the next five years were mixed this morning. Although many praised the effort and the vision of the programme of work, in particular its alignment with the United Nations Sustainable Development Goals, a number of countries found the programme ambitious without the needed financial backing, and sometimes straying from the core function of the organisation.

Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019

As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019.

US NAFTA Negotiating Objectives For IP? Go Big On Digital IP Protection, Fend Off GIs

The Office of the United States Trade Representative (USTR) has issued a set of negotiating objectives for renegotiating the 1994 North American Free Trade Agreement (NAFTA) that include its hopes for elevating intellectual property in the trade deal. Included in the list: force Canada and Mexico to ratify international treaties, accept US law on IP protection and create conditions for "strong" IP enforcement especially online, and ensure ample protection for products with generic names. Perhaps oddly, there is only one mention of trade, which includes respect for a 2001 text at the World Trade Organization on IP and public health.

Rise Of Global Value Chains Propels Intangible Capital Revenues, WIPO Report Says

A World Intellectual Property Organization report released today shows the growing global importance of intangible capital and its share in the value of end products. The report does not however provide a geographical repartition of this value, nor who actually owns the returns on intangible capital. Three case studies shed light on different production areas: coffee, smart phones, and solar panels.

New Proposal At WIPO On Exceptions To Broadcasting Rights

While World Intellectual Property Organization delegates held informal closed consultations at the beginning of this week on a potential treaty protecting rights of broadcasting organisations from signal theft and piracy, a group of Latin American countries has proposed language on limitations and exceptions to these rights.